118 related articles for article (PubMed ID: 38682343)
1. Investigation of the effects of thiazole compounds on thioredoxin reductase 1 (TrxR1), glutathione S-transferase (GST), and glutathione reductase (GR) targeted human brain glioblastoma cancer (U-87 MG).
Korkmaz IN
Biotechnol Appl Biochem; 2024 Apr; ():. PubMed ID: 38682343
[TBL] [Abstract][Full Text] [Related]
2. Correlations between the activities of 19 standard anticancer agents, antioxidative enzyme activities and the expression of ATP-binding cassette transporters: comparison with the National Cancer Institute data.
Bracht K; Liebeke M; Ritter CA; Grünert R; Bednarski PJ
Anticancer Drugs; 2007 Apr; 18(4):389-404. PubMed ID: 17351391
[TBL] [Abstract][Full Text] [Related]
3. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine.
Anestål K; Arnér ES
J Biol Chem; 2003 May; 278(18):15966-72. PubMed ID: 12574159
[TBL] [Abstract][Full Text] [Related]
4. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
[TBL] [Abstract][Full Text] [Related]
5. Further insight into the impact of sodium selenite on selenoenzymes: high-dose selenite enhances hepatic thioredoxin reductase 1 activity as a consequence of liver injury.
Zhang J; Wang H; Peng D; Taylor EW
Toxicol Lett; 2008 Feb; 176(3):223-9. PubMed ID: 18215477
[TBL] [Abstract][Full Text] [Related]
6. Nitrovin (difurazone), an antibacterial growth promoter, induces ROS-mediated paraptosis-like cell death by targeting thioredoxin reductase 1 (TrxR1).
Zhao L; Zhong B; Zhu Y; Zheng H; Wang X; Hou Y; Lu JJ; Ai N; Guo X; Ge W; Ma YY; Chen X
Biochem Pharmacol; 2023 Apr; 210():115487. PubMed ID: 36893814
[TBL] [Abstract][Full Text] [Related]
7. Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase.
Peng X; Xu J; Arnér ES
Biochem J; 2012 Oct; 447(1):167-74. PubMed ID: 22784015
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance.
Engelman R; Ziv T; Arnér ESJ; Benhar M
Free Radic Biol Med; 2016 Aug; 97():375-385. PubMed ID: 27377780
[TBL] [Abstract][Full Text] [Related]
9. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
Zhang H; Wu J; Yuan J; Li H; Zhang Y; Wu W; Chen W; Wang C; Meng S; Chen S; Huo M; He Y; Zhang C
J Exp Clin Cancer Res; 2021 Aug; 40(1):260. PubMed ID: 34412665
[TBL] [Abstract][Full Text] [Related]
10. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
Du Y; Zhang H; Lu J; Holmgren A
J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
[TBL] [Abstract][Full Text] [Related]
11. Serum glutathione-S-transferase and glutathione reductase activity in head and neck cancer patients.
Patel BP; Raval GN; Rawal RM; Patel JB; Sainger RN; Patel MM; Shah MH; Patel DD; Patel PS
Neoplasma; 2002; 49(4):260-6. PubMed ID: 12382026
[TBL] [Abstract][Full Text] [Related]
12. Structure-Activity Relationship of Methyl 4-Aminobenzoate Derivatives as Being Drug Candidate Targeting Glutathione Related Enzymes: in Vitro and in Silico Approaches.
Korkmaz IN; Güller U; Kalın R; Özdemir H; Küfrevioğlu Öİ
Chem Biodivers; 2023 May; 20(5):e202201220. PubMed ID: 37043708
[TBL] [Abstract][Full Text] [Related]
13. Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells.
van Gisbergen MW; Cebula M; Zhang J; Ottosson-Wadlund A; Dubois L; Lambin P; Tew KD; Townsend DM; Haenen GR; Drittij-Reijnders MJ; Saneyoshi H; Araki M; Shishido Y; Ito Y; Arnér ES; Abe H; Morgenstern R; Johansson K
Mol Pharm; 2016 Jun; 13(6):2010-25. PubMed ID: 27093577
[TBL] [Abstract][Full Text] [Related]
14. Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells.
Kalın ŞN; Altay A; Budak H
Chem Biol Interact; 2022 Jul; 361():109984. PubMed ID: 35569514
[TBL] [Abstract][Full Text] [Related]
15. Chlorophyllin Inhibits Mammalian Thioredoxin Reductase 1 and Triggers Cancer Cell Death.
Sun S; Zhang Y; Xu W; Zhang Y; Yang R; Guo J; Guan S; Ma Q; Ma K; Xu J
Antioxidants (Basel); 2021 Oct; 10(11):. PubMed ID: 34829604
[TBL] [Abstract][Full Text] [Related]
16. Menadione inhibits thioredoxin reductase 1 via arylation at the Sec
Sun S; Xu W; Zhang Y; Yang Y; Ma Q; Xu J
Free Radic Biol Med; 2021 Aug; 172():482-489. PubMed ID: 34186208
[TBL] [Abstract][Full Text] [Related]
17. The role of thioredoxin reductase activity in selenium-induced cytotoxicity.
Madeja Z; Sroka J; Nyström C; Björkhem-Bergman L; Nordman T; Damdimopoulos A; Nalvarte I; Eriksson LC; Spyrou G; Olsson JM; Björnstedt M
Biochem Pharmacol; 2005 Jun; 69(12):1765-72. PubMed ID: 15935149
[TBL] [Abstract][Full Text] [Related]
18. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy.
Eriksson SE; Prast-Nielsen S; Flaberg E; Szekely L; Arnér ES
Free Radic Biol Med; 2009 Dec; 47(11):1661-71. PubMed ID: 19766715
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of thioredoxin reductase 1 by vulpinic acid suppresses the proliferation and migration of human breast carcinoma.
Kalın ŞN; Altay A; Budak H
Life Sci; 2022 Dec; 310():121093. PubMed ID: 36270425
[TBL] [Abstract][Full Text] [Related]
20. Molecular Docking Studies and the Effect of Fluorophenylthiourea Derivatives on Glutathione-Dependent Enzymes.
Demir Y; Türkeş C; Küfrevioğlu Öİ; Beydemir Ş
Chem Biodivers; 2023 Jan; 20(1):e202200656. PubMed ID: 36538730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
